0001398344-20-015789.txt : 20200814 0001398344-20-015789.hdr.sgml : 20200814 20200814091715 ACCESSION NUMBER: 0001398344-20-015789 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20200630 FILED AS OF DATE: 20200814 DATE AS OF CHANGE: 20200814 EFFECTIVENESS DATE: 20200814 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Essex Woodlands Management, Inc. CENTRAL INDEX KEY: 0001542339 IRS NUMBER: 200389009 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-14839 FILM NUMBER: 201101763 BUSINESS ADDRESS: STREET 1: 21 WATERWAY AVE STREET 2: STE 225 CITY: THE WOODLANDS STATE: TX ZIP: 77380 BUSINESS PHONE: 281-364-1555 MAIL ADDRESS: STREET 1: 21 WATERWAY AVE STREET 2: STE 225 CITY: THE WOODLANDS STATE: TX ZIP: 77380 FORMER COMPANY: FORMER CONFORMED NAME: Essex Woodlands Health Ventures, Inc. DATE OF NAME CHANGE: 20120214 13F-HR 1 primary_doc.xml 13F-HR LIVE false false false 0001542339 XXXXXXXX 06-30-2020 06-30-2020 false Essex Woodlands Management, Inc.
21 WATERWAY AVE STE 225 THE WOODLANDS TX 77380
13F HOLDINGS REPORT 028-14839 N
Richard Kolodziejcyk Chief Compliance Officer and Chief Financial Officer 281-364-1555 /s/ Richard Kolodziejcyk The Woodlands TX 08-14-2020 0 8 203849
INFORMATION TABLE 2 fp0056100_13fhr-table.xml 13F INFORMATION TABLE AXOGEN INC COM 05463X106 22453 2429999 SH SOLE 2429999 0 0 CATALYST BIOSCIENCES INC COM NEW 14888D208 462 78622 SH SOLE 78622 0 0 ENDOLOGIX INC COM NEW 29266S304 101 125747 SH SOLE 125747 0 0 EYEPOINT PHARMACEUTICALS INC COM 30233G100 31851 41909219 SH SOLE 41909219 0 0 MEDICINOVA INC COM NEW 58468P206 5994 1105941 SH SOLE 1105941 0 0 REVANCE THERAPEUTICS INC COM 761330109 81613 3342047 SH SOLE 3342047 0 0 TELA BIO, INC. COM 872381108 18037 1391768 SH SOLE 1391768 0 0 VENUS CONCEPT, INC. COM 92332W105 43338 12417856 SH SOLE 12417856 0 0